Balance Sheet Data

Gilead Sciences, Inc. (GILD)

$89.16

+1.37 (+1.56%)

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 25,51030,08924,3527,4086,52021,995.5222,368.5722,747.9623,133.7823,526.15
Total Cash (%)
Account Receivables 3,8513,3273,5824,8924,4934,554.654,631.904,710.464,790.364,871.60
Account Receivables (%)
Inventories 8018149221,6831,6181,310.461,332.681,355.291,378.271,401.65
Inventories (%)
Accounts Payable 814790713844705881.07896.01911.21926.67942.38
Accounts Payable (%)
Capital Expenditure -590-924-825-650-579-825.49-839.49-853.73-868.21-882.94
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.